Trials / Sponsors / Kanto CML Study Group
Kanto CML Study Group
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial Myelogenous Leukemia, Chronic, Chronic Phase | Phase 2 | 2012-11-01 |
| Unknown | Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myelogenous Leukemia, Chronic, Chronic Phase | — | 2011-07-01 |
| Completed | A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Da Chronic Myeloid Leukemia | Phase 2 | 2011-04-01 |
| Completed | A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia Chronic Myeloid Leukemia | Phase 2 | 2009-03-01 |